Tuesday, 15 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14389
Articles
Company
Deals
TenNor Therapeutics Files Hong Kong IPO for Anti-Infective Pipeline
February 4, 2026
Company
Drug
BeBetter Med BEBT-701 Approved for Hypertension siRNA Trial
February 4, 2026
Company
Drug
AbbVie Files Rinvoq for Vitiligo Approval in US and EU
February 4, 2026
Company
Drug
Datroway TNBC sBLA Gets FDA Priority Review for Triple-Negative Breast Cancer
February 4, 2026
Company
Drug
Bayer Nubeqa Gets NMPA Approval for Metastatic Prostate Cancer
February 4, 2026
Company
Daiichi Sankyo Discontinues DS-9606 ADC, Delays Dato-DXd Data
February 4, 2026
Company
Deals
Insilico Medicine Doses First Patient in MEN2501 Phase I, Triggers $5M Menarini Milestone
February 3, 2026
Company
Deals
PrimeGenX Therapeutics Files Hong Kong IPO for Pumecitinib Platform
February 3, 2026
Company
Medical Device
Hengrui Resubmits Camrelizumab-Apatinib BLA for HCC to FDA
April 21, 2026
Company
Deals
Jumpcan Licenses PrimeGenX Pumecitinib Nasal Spray for Allergic Rhinitis
February 3, 2026
Company
Medical Device
ZEISS ARTEVO Gets NMPA Approval for China Ophthalmology Market
February 3, 2026
Company
Drug
Venglustat Gaucher: Sanofi Meets Primary Endpoint in Phase 3 LEAP2MONO Study
February 3, 2026
1
2
…
168
169
170
171
172
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?